Following is a cumulative list of Hoosier Cancer Research Network publications in multiple myeloma.

Manuscripts and Journal Articles

• Attaya Suvannasankha, Christopher Fausel, Beth E. Juliar, Constantin T. Yiannoutsos, William B. Fisher, Rafat H. Ansari, Lisa L. Wood, Gina G. Smith, Larry D. Cripe, Rafat Abonour. Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone (CTP) for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial: MM01-21. The Oncologist, Vol. 12, No. 1, 99-106, January 2007

Abstracts, Posters, and Presentations

• Final Report of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone (CTP) for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial: MM01-21. Accepted as a poster presentation for the ASCO Annual Meeting, May 13 – 17, 2005, Orlando, FL
• Rafat Abonour, Kristen Ganjoo, Christopher Fausel, Constantin Yiannoutsos, Beth E. Juliar, Lisa Wood, Gina Smith, Paul Walker, Larry Cripe. A Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone (CTP) for Patients with Relapsed or Refractory Multiple Myeloma, A Hoosier Oncology Group Trial: MM01-21. Accepted as a poster presentation for ASH Annual Meeting December 6-9, 2003, San Diego, CA.